Evidence map›Paper›PMID 35562672›Full record

ArticleBMC medical research methodology2022

Global prediction model for COVID-19 pandemic with the characteristics of the multiple peaks and local fluctuations.

Haoran Dai, Wen Cao, Xiaochong Tong, Yunxing Yao, Feilin Peng, Jingwen Zhu, Yuzhen Tian

Abstract read
In one paragraph

Article in BMC medical research methodology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haoran DaiSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China.
Wen CaoSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China. jwzx_edifier@163.com.
Xiaochong TongSchool of Geospatial Information, University of Information Engineering, Zhengzhou, 450001, China.
Yunxing YaoSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China.
Feilin PengSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China.
Jingwen ZhuSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China.
Yuzhen TianSchool of Geoscience and Technology, Zhengzhou University, Zhengzhou, 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the spread of COVID-19, the time-series prediction of COVID-19 has become a research hotspot. Unlike previous epidemics, COVID-19 has a new pattern of long-time series, large fluctuations, and multiple peaks. Traditional dynamical models are limited to curves with short-time series, single peak, smoothness, and symmetry. Secondly, most of these models have unknown parameters, which bring greater ambiguity and uncertainty. There are still major shortcomings in the integration of multiple factors, such as human interventions, environmental factors, and transmission mechanisms.

methodsA dynamical model with only infected humans and removed humans was established. Then the process of COVID-19 spread was segmented using a local smoother. The change of infection rate at different stages was quantified using the continuous and periodic Logistic growth function to quantitatively describe the comprehensive effects of natural and human factors. Then, a non-linear variable and NO

resultsThe experiments and analysis showed the R

conclusionThe model can not only better describe the effects of human interventions but also better simulate the temporal evolution of COVID-19 with local fluctuations and multiple peaks, which can provide valuable assistant decision-making information.

Indexed as

COVID-19BrazilHumansIndiaPandemicsSARS-CoV-2Compartmental modelCOVID-19Epidemic predictionLogistic growth functionNO2 concentrations

Identifiers

PMID35562672
PMCPMC9100309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.